Abstract
Purpose
Besides typical clinical symptoms, primary hyperparathyroidism (pHPT) is associated with impaired quality of life and cognitive status. The aim of this study was to evaluate the quality of life and cognitive impairment in patients with pHPT, before and after parathyroidectomy.
Methods
We conducted a panel study, which included asymptomatic pHPT patients scheduled for parathyroidectomy. Besides demographic and clinical data, patients’ quality of life and cognitive capacity were recorded before, 1 month, and 6 months following parathyroidectomy using the Short Form 36 questionnaire (RAND-36), Beck Depression Inventory (BDI), Depression Anxiety Stress Scales (DASS), Mini-Mental State Examination (MMSE), and Symptom Check List 90—revised version (SCL90R).
Results
During a 2-year follow-up, 101 patients entered the study (88 women), with an average age of 60.7 years. The Global score of RAND-36 test ameliorated by almost 50% 6 months after parathyroidectomy. The most sustained subscores of the RAND-36 test were role functioning/physical and health change, with an improvement of more than 125%. According to the BDI, DASS depression subscore, and SCL90R depression subscore, the extent of depressive symptoms reduction was approximately 60% 6 months postoperatively. The level of anxiety was reduced by 62.4%, measured by both the DASS and SCL90R anxiety subscores. The stress level was almost halved according to the DASS stress subscore (from 10.7 to 5.6 points). The results of the MMSE test showed a significant improvement postoperatively, for 1.2 points (4.4%). A worse preoperative score of each tool was related to the higher magnitude of improvement 6 months after parathyroidectomy.
Conclusion
A considerable number of pHPT patients, even without other typical symptoms, show signs of impaired quality of life and neurocognitive status preoperatively. After a successful parathyroidectomy, there is an improvement in quality of life, declined levels of depression, anxiety, and stress, as well as amelioration of cognitive status. Patients with more impaired quality of life and pronounced neurocognitive symptoms may expect more benefits from the surgery.
Similar content being viewed by others
References
M.L. Griebeler, A.E. Kearns, E. Ryu, M.A. Hathcock, L.J. Melton, R.A. Wermers, Secular trends in the incidence of primary hyperparathyroidism over five decades (1965–2010). Bone. 73, 1–7 (2015). https://doi.org/10.1016/j.bone.2014.12.003
J.P. Bilezikian, N.E. Cusano, A.A. Khan, J.M. Liu, C. Marcocci, F. Bandeira, Primary hyperparathyroidism. Nat. Rev. Dis. Primers 2, 16033 (2016). https://doi.org/10.1038/nrdp.2016.33
M.D. Jovanovic, V.R. Zivaljevic, A.D. Diklic, B.R. Rovcanin, G. V Zoric, I.R. Paunovic, Surgical treatment of concomitant thyroid and parathyroid disorders: analysis of 4882 cases. Eur. Arch. Otorhinolaryngol. 274, 997–1004 (2017). https://doi.org/10.1007/s00405-016-4303-z
B.C. Silva, N.E. Cusano, J.P. Bilezikian, Primary hyperparathyroidism. Best Pract. Res. Clin. Endocrinol. Metab. 101247 (2018). https://doi.org/10.1016/j.beem.2018.09.013
J.P. Bilezikian, A.A. Khan, S.J. Silverberg, G.E. Fuleihan, C. Marcocci, S. Minisola, N. Perrier, A. Sitges-Serra, R.V. Thakker, G. Guyatt, M. Mannstadt, J.T. Potts, B.L. Clarke, M.L. Brandi; International Workshop on Primary Hyperparathyroidism, Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner. Res. 37, 2293–2314 (2022). https://doi.org/10.1002/jbmr.4677
H. Ejlsmark-Svensson, T. Sikjaer, S.M. Webb, L. Rejnmark, L. Rolighed, Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: a prospective cohort study. Clin. Endocrinol. (Oxf) 90, 184–191 (2019). https://doi.org/10.1111/cen.13865
R. Mihai, G.P. Sadler, Pasieka’s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J. Surg. 32, 807–14 (2008). https://doi.org/10.1007/s00268-008-9509-9
R. Dulfer, W. Geilvoet, A. Morks, E.M. van Lieshout, C.P. Smit, Nieveen, E.J. van Dijkum, K. In’t Hof, F. van Dam, C.H. van Eijck, P.W. de Graaf, T.M. van Ginhoven, Impact of parathyroidectomy for primary hyperparathyroidism on quality of life: a case-control study using Short Form Health Survey 36. Head Neck 38, 1213–20 (2016). https://doi.org/10.1002/hed.24499
K. Brito, S. Edirimanne, G.D. Eslick, The extent of improvement of health-related quality of life as assessed by the SF36 and Paseika scales after parathyroidectomy in patients with primary hyperparathyroidism–a systematic review and meta-analysis. Int. J. Surg. 13, 245–249 (2015). https://doi.org/10.1016/j.ijsu.2014.12.004
S.M. Wilhelm, T.S. Wang, D.T. Ruan, J.A. Lee, S.L. Asa, Q.Y. Duh, G.M. Doherty, M.F. Herrera, J.L. Pasieka, N.D. Perrier, S.J. Silverberg, C.C. Solórzano, C. Sturgeon, M.E. Tublin, R. Udelsman, S.E. Carty, The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 151, 959–968 (2016)
L. Lins, F.M. Carvalho, SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med. 4, 2050312116671725 (2016). https://doi.org/10.1177/2050312116671725
A.T. Beck, C.H. Ward, M. Mendelson, J. Mock, J. Erbaugh, An inventory for measuring depression. Arch. Gen. Psychiatry 4, 561–71 (1961). https://doi.org/10.1001/archpsyc.1961.01710120031004
P.F. Lovibond, S.H. Lovibond, The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav. Res. Ther. 33, 335–43 (1995). https://doi.org/10.1016/0005-7967(94)00075-u
V. Jovanovic, V. Gavrilov-Jerkovic, D. Zuljevic et al. Psychometric evaluation of Depression Anxiety Stress Scale 21 (DASS-21) in students in Serbia. Psihologija 47, 93–112 (2014). https://doi.org/10.2298/PSI1401093J
M.F. Folstein, S.E. Folstein, P.R. McHugh, Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–98 (1975). https://doi.org/10.1016/0022-3956(75)90026-6
L.R. Derogatis, K. Rickels, A.F. Rock, The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br. J. Psychiatry 128, 280–9 (1976). https://doi.org/10.1192/bjp.128.3.280
J. Livschitz, T.W.F. Yen, D.B. Evans, T.S. Wang, S. Dream. Long-term quality of life after parathyroidectomy for primary hyperparathyroidism: a systematic review. JAMA Surg. (2022). https://doi.org/10.1001/jamasurg.2022.4249
T. Weber, J. Eberle, U. Messelhäuser, L. Schiffmann, C. Nies, J. Schabram, A. Zielke, K. Holzer, E. Rottler, D. Henne-Bruns, M. Keller, J. von Wietersheim, Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg. 148, 109–15 (2013). https://doi.org/10.1001/2013.jamasurg.316
S.A. Roman, J.A. Sosa, L. Mayes et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 138, 1121–1128 (2005). https://doi.org/10.1016/j.surg.2005.08.033
A. Koman, R. Bränström, Y. Pernow, R. Bränström, I.L. Nilsson, F. Granath, Neuropsychiatric comorbidity in primary hyperparathyroidism before and after parathyroidectomy: a population study. World J. Surg. 46, 1420–1430 (2022). https://doi.org/10.1007/s00268-022-06485-1
K. Jovanovic, N. Kalezic, S. Sipetic Grujicic, V. Zivaljevic, M. Jovanovic, B. Kukic, R. Trailovic, P. Zlatanovic, P. Mutavdzic, I. Tomic, N. Ilic, L. Davidovic, Preoperative anxiety is associated with postoperative complications in vascular surgery: a cross-sectional study. World J. Surg. 46, 1987–1996 (2022). https://doi.org/10.1007/s00268-022-06575-0
A. Bedaso, N. Mekonnen, B. Duko, Prevalence and factors associated with preoperative anxiety among patients undergoing surgery in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open 12, e058187 (2022). https://doi.org/10.1136/bmjopen-2021-058187
C. Cipriani, L. Cianferotti, Quality of life in primary hyperparathyroidism. Endocrinol. Metab. Clin. North Am. 51, 837–852 (2022). https://doi.org/10.1016/j.ecl.2022.04.007
S.A. Roman, J.A. Sosa, R.H. Pietrzak, P.J. Snyder, D.C. Thomas, R. Udelsman, L. Mayes, The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann. Surg. 253, 131–7 (2011). https://doi.org/10.1097/SLA.0b013e3181f66720
A. Trombetti, E.R. Christ, C. Henzen, G. Gold, M. Brändle, F.R. Herrmann, C. Torriani, F. Triponez, M. Kraenzlin, R. Rizzoli, C. Meier, Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms. J. Endocrinol. Invest. 39, 567–76 (2016). https://doi.org/10.1007/s40618-015-0423-3
D. Babińska, M. Barczyński, T. Stefaniak, T. Osęka, A. Babińska, D. Babiński, K. Sworczak, A.J. Lachiński, W. Nowak, Z. Sledziński, Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism. Langenbecks Arch. Surg. 397, 825–31 (2012). https://doi.org/10.1007/s00423-011-0885-5
M. Liu, M. Sum, E. Cong, I. Colon, M. Bucovsky, J. Williams, A. Kepley, J. Kuo, J.A. Lee, R.M. Lazar, R. Marshall, S. Silverberg, M.D. Walker, Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy. J. Endocrinol. Invest. 43, 369–379 (2020). https://doi.org/10.1007/s40618-019-01128-0
C.F. Bell, M.M. Warrick, K.C. Gallagher, N. Baregamian, Neurocognitive performance profile postparathyroidectomy: a pilot study of computerized assessment. Surgery 163, 457–462 (2018). https://doi.org/10.1016/j.surg.2017.09.001
M.P. Björkman, A.J. Sorva, R.S. Tilvis, Does elevated parathyroid hormone concentration predict cognitive decline in older people. Aging Clin. Exp. Res. 22, 164–9 (2010). https://doi.org/10.1007/BF03324791
M.T. Schram, S. Trompet, A.M. Kamper, A.J. de Craen, A. Hofman, S.M. Euser, M.M. Breteler, R.G. Westendorp, Serum calcium and cognitive function in old age. J. Am. Geriatr Soc. 55, 1786–92 (2007). https://doi.org/10.1111/j.1532-5415.2007.01418.x
E.C. Toescu, M. Vreugdenhil, Calcium and normal brain ageing. Cell Calcium 47, 158–64 (2010). https://doi.org/10.1016/j.ceca.2009.11.013
T.F. Cermik, M. Kaya, B. Uğur-Altun, D. Bedel, S. Berkarda, O.N. Yiğitbaşi, Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism. Neuroradiology 49, 379–85 (2007). https://doi.org/10.1007/s00234-006-0198-5
I. Lourida, J. Thompson-Coon, C.M. Dickens, M. Soni, E. Kuźma, K. Kos, D.J. Llewellyn, Parathyroid hormone, cognitive function and dementia: a systematic review. PLoS One 10, e0127574 (2015). https://doi.org/10.1371/journal.pone.0127574
J.W. Christensen, K.F. Thøgersen, L.T. Jensen, M. Krakauer, B. Kristensen, F.N. Bennedbæk, B. Zerahn, Changes in quality of life 6 months after parathyroidectomy for primary hyperparathyroidism. Endocr. Connect 11, e210630 (2022). https://doi.org/10.1530/EC-21-0630
P. Ramakant, A.K. Verma, G. Chand, A. Mishra, G. Agarwal, A. Agarwal, S.K. Mishra, Salutary effect of parathyroidectomy on neuropsychiatric symptoms in patients with primary hyperparathyroidism: evaluation using PAS and SF-36v2 scoring systems. J. Postgrad. Med. 57, 96–101 (2011). https://doi.org/10.4103/0022-3859.81859
S. Frey, B. Perrot, C. Caillard, M. Le Bras, M. Gérard, C. Blanchard, B. Cariou, M. Wargny, E. Mirallié, Parathyroidectomy for primary hyperparathyroidism: effect on quality of life after 3 years - a prospective cohort study. Int. J. Surg. 109, 364–373 (2023). https://doi.org/10.1097/JS9.0000000000000282
K.J. Leong, R.C. Sam, A.W. Garnham, Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population. Surgeon. 8, 5–8 (2010). https://doi.org/10.1016/j.surge.2009.10.005
L. Meng, S. Liu, A. Al-Dayyeni, Z. Sheng, Z. Zhou, X. Wang, Comparison of initial clinical presentations between primary hyperparathyroidism patients from New Brunswick and Changsha. Int. J. Endocrinol. 2018, 6282687 (2018). https://doi.org/10.1155/2018/6282687
S.J. Silverberg, B.L. Clarke, M. Peacock, F. Bandeira, S. Boutroy, N.E. Cusano, D. Dempster, E.M. Lewiecki, J.M. Liu, S. Minisola, L. Rejnmark, B.C. Silva, M.D. Walker, J.P. Bilezikian, Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3580–94 (2014). https://doi.org/10.1210/jc.2014-1415
F. De Lucia, S. Minisola, E. Romagnoli, J. Pepe, C. Cipriani, A. Scillitani, N. Parikh, D.S. Rao, Effect of gender and geographic location on the expression of primary hyperparathyroidism. J Endocrinol. Invest. 36, 123–6 (2013). https://doi.org/10.3275/8455
Ö. Makay, B. Özçınar, T. Şimşek, C. Arıcı, B. Güngör, S. Özbaş, T. Akça, A.U. Emre, G. Karadeniz Çakmak, M. Akçay, B. Ünal, M. Girgin, S. Girgin, S. Görgülü, A. Sezer, A. Karataş, İ.A. Özemir, N. Aksakal, S. Erel, M.Ü. Uğurlu, A.İ. Filiz, C. Atalay, A. Uzunköy, U. Deveci, Ç. Kotan, G. İçöz, Y. Kurt, A. Kebudi, N.Z. Cantürk, Y. Erbil, R. Pandev, B.M. Güllüoğlu, Regional clinical and biochemical differences among patients with primary hyperparathyroidism. Balkan. Med. J. 34, 28–34 (2017). https://doi.org/10.4274/balkanmedj.2015.0865
S. Shah-Becker, J. Derr, B.S. Oberman, A. Baker, B. Saunders, M.M. Carr, D. Goldenberg, Early neurocognitive improvements following parathyroidectomy for primary hyperparathyroidism. Laryngoscope. 128, 775–780 (2018). https://doi.org/10.1002/lary.26617
T. Weber, M. Keller, I. Hense, A. Pietsch, U. Hinz, T. Schilling, P. Nawroth, E. Klar, M.W. Büchler, Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J. Surg. 31, 1202–9 (2007). https://doi.org/10.1007/s00268-007-9006-6
Y. Wang, Y. Xin, T. Zhao T., H. Shen, X. Liu, J. Wang, Q. Wang, R. Shen, D. Feng, B. Wei. PTH levels, sleep quality, and cognitive function in primary hyperparathyroidism. Endocrine. (2023). https://doi.org/10.1007/s12020-023-03410-x
A. Szalat, N. Tamir, H. Mazeh, J.P. Newman, Successful parathyroidectomy improves cognition in patients with primary hyperparathyroidism: a prospective study in a tertiary medical center and comprehensive review of the literature. Front. Endocrinol. (Lausanne) 13, 1095189 (2022). https://doi.org/10.3389/fendo.2022.1095189
Funding
The study was supported by the Ministry of the Education and Science of the Republic of Serbia (grant No 175042).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
The survey part of the study was approved by the Medical Ethical Committee of Faculty of Medicine, University of Belgrade.
Informed consent
Written informed consent was obtained from all participants.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jovanovic, M., Zivaljevic, V., Sipetic Grujicic, S. et al. Effects of successful parathyroidectomy on neuropsychological and cognitive status in patients with asymptomatic primary hyperparathyroidism. Endocrine 81, 592–601 (2023). https://doi.org/10.1007/s12020-023-03426-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03426-3